Decode-Led Study Suggests Genetics May Refine PSA Testing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – An international research group led by investigators at Decode Genetics reported online today in Science Translational Medicine that they have uncovered genetic loci that they believe will be useful for improving the accuracy of prostate cancer screening based on prostate-specific antigen, or PSA, levels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.